Prenatal surgery for congenital diaphragmatic hernia

Jeff Ying-Kit Au-Yeung1, Kwong-Leung Chan

  • 1Department of Surgery, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong, China.

Asian Journal of Surgery
|October 8, 2003
PubMed

Insights

Congenital diaphragmatic hernia (CDH) treatment has improved with Fetendo-PLUG, a minimally invasive fetal tracheal occlusion technique. This method offers a 75% survival rate, reducing complications for both mother and fetus.

Area of Science:

  • Medical Science
  • Surgical Innovation
  • Fetal Medicine

Background:

  • Congenital diaphragmatic hernia (CDH) presents a high mortality rate, up to 77%, even with advanced care.
  • Poor prognostic indicators include liver herniation, low lung-to-head ratio, and diagnosis before 24 weeks gestation.
  • Current in utero open repair strategies have not improved survival rates.

Purpose of the Study:

  • To evaluate the efficacy and safety of Fetendo-PLUG, a minimally invasive fetal tracheal occlusion technique for CDH.
  • To compare Fetendo-PLUG outcomes with standard postnatal care and open hysterotomy fetal tracheal occlusion.
  • To explore advancements in fetal surgical instrumentation for CDH management.

Main Methods:

  • Development of Fetendo-PLUG: a video-fetoscopic intrauterine technique for tracheal occlusion.
  • Refinement using a detachable balloon via a single 5 mm port under ultrasound guidance.
  • Comparison of outcomes between Fetendo-PLUG, standard care, and open hysterotomy procedures.

Main Results:

  • Fetendo-PLUG demonstrated a significantly higher survival rate of 75% compared to other methods.
  • This technique resulted in fewer fetal and maternal complications.
  • Minimally invasive approach reduced risks of recurrent laryngeal nerve injury and vocal cord paresis.

Conclusions:

  • Fetendo-PLUG represents a promising advancement in managing congenital diaphragmatic hernia.
  • Minimally invasive fetal tracheal occlusion offers improved survival and reduced complications.
  • Further research is needed to refine fetal instrumentation and develop better tocolytic drugs.

Related Concept Videos